Synlab AG carries a market capitalization of 2.43B, placing it among publicly traded companies globally. Its enterprise value stands at 3.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.43B |
| Enterprise Value | 3.73B |
Synlab AG currently has 219.78M shares outstanding.
| Shares Outstanding | 219.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Synlab AG trades at a trailing price-to-earnings ratio of 27.83. The price-to-sales ratio is 0.95, and the price-to-book ratio stands at -4.51.
| PE Ratio | 27.83 |
| PS Ratio | 0.95 |
| PB Ratio | -4.51 |
| P/TBV Ratio | -5.87 |
| P/FCF Ratio | 4.59 |
| P/OCF Ratio | 5.94 |
On an enterprise value basis, Synlab AG trades at an EV/EBITDA multiple of 24.57 and an EV/FCF ratio of 6.07. The EV/Sales ratio of 1.43 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.57 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.43 |
| EV / EBITDA | 24.57 |
| EV / EBIT | 24.57 |
| EV / FCF | 6.07 |
Synlab AG maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.21, indicating elevated leverage, while an interest coverage ratio of 1.35 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.24 |
| Quick Ratio | 0.43 |
| Debt / Equity | 65.21 |
| Debt / EBITDA | 10.18 |
| Interest Coverage | 1.35 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 1.80 |
| Return on Invested Capital (ROIC) | 2.35 |
| Return on Capital Employed (ROCE) | 13.22 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.63 |
Over the trailing twelve months, Synlab AG has paid 49.56M in income taxes, reflecting an effective tax rate of 35.52.
| Income Tax | 49.56M |
| Effective Tax Rate | 35.52 |
Synlab AG's stock has gained approximately 18.28877% over the past 52 weeks. The 50-day moving average sits at 10.84, while the 200-day moving average is 11.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 18.28877% |
| 50-Day Moving Average | 10.84 |
| 200-Day Moving Average | 11.02 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Synlab AG generated 2.62B in revenue and converted that into 89.35M in net income, yielding earnings per share of 0.40. EBITDA reached 151.79M, while operating income came in at 151.79M.
| Revenue | 2.62B |
| Gross Profit | 2.01B |
| Operating Income | 151.79M |
| Pretax Income | 139.56M |
| Net Income | 89.35M |
| EBITDA | 151.79M |
| EBIT | 151.79M |
| Earnings Per Share (EPS) | 0.40 |
Synlab AG holds 300.47M in cash and equivalents against 1.55B in total debt, resulting in a net debt position of 664.59M. Total book value stands at -551.70M, with working capital of 166.41M providing operational flexibility.
| Cash & Cash Equivalents | 300.47M |
| Total Debt | 1.55B |
| Net Debt | 664.59M |
| Equity (Book Value) | -551.70M |
| Book Value Per Share | -2.43 |
| Working Capital | 166.41M |
Synlab AG produced 418.86M in operating cash flow over the past twelve months. After subtracting -123.33M in capital expenditures, free cash flow totaled 295.53M - equivalent to 1.30 per share.
| Operating Cash Flow | 418.86M |
| Capital Expenditures | -123.33M |
| Free Cash Flow | 295.53M |
| FCF Per Share | 1.30 |
Synlab AG operates with a gross margin of 76.87, reflecting its pricing power and cost economics. The operating margin of 5.80 and net profit margin of 3.42 provide insight into operational efficiency.
| Gross Margin | 76.87 |
| Operating Margin | 5.80 |
| Pretax Margin | 5.34 |
| Profit Margin | 3.42 |
| EBITDA Margin | 5.80 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 29.58 |
| FCF Yield | 21.81 |
Synlab AG posts an Altman Z-Score of 1.80, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.80 |